Alzheimer's Disease
Alzheimer's disease is a progressive neurological disorder that affects memory, thinking, and behavior. It is the most common cause of dementia, leading to a decline in cognitive function and daily living skills.
We are examining how the immune system reacts in participants who received Posdinemab. This research aims to improve our understanding of its effects on the immune system.
Health conditions and diseases that the clinical trial is designed to study and treat.
Alzheimer's disease is a progressive neurological disorder that affects memory, thinking, and behavior. It is the most common cause of dementia, leading to a decline in cognitive function and daily living skills.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.